INTC
36
-3
UA
15
-32
RRC
62
-16
NKE
40
-3
PFG
53
-18
PRU
62
-18
SO
48
-29
PSA
46
-18
WMB
47
-21
F
56
-6
JBHT
60
-3
SYY
48
-20
UNM
72
-7
LH
43
-5
EBAY
52
4
RHI
40
-12
L
69
4
STZ
47
-12
EMC
76
22
UHS
52
-16
INTC
36
-3
UA
15
-32
RRC
62
-16
NKE
40
-3
PFG
53
-18
PRU
62
-18
SO
48
-29
PSA
46
-18
WMB
47
-21
F
56
-6
JBHT
60
-3
SYY
48
-20
UNM
72
-7
LH
43
-5
EBAY
52
4
RHI
40
-12
L
69
4
STZ
47
-12
EMC
76
22
UHS
52
-16
Financhill
Back

Virtus Stone Harbor Emerging Markets Income Fund Vs. Zenas BioPharma, Inc. Industry Stock Comparison

Sell
28

EDF
Virtus Stone Harbor Emerging Markets Income Fund

Last Price:
$4.82
Seasonality Move:
3.41%
Sell
29

ZBIO
Zenas BioPharma, Inc.

Last Price:
$34.78
Seasonality Move:
0.59%
Sell
28
Virtus Stone Harbor Emerging Markets Income Fund (EDF) is a Sell

Is Virtus Stone Harbor Emerging Markets Income Fund a Buy, Sell or Hold?

  • The current Virtus Stone Harbor Emerging Markets Income Fund [EDF] share price is $4.79. The Score for EDF is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • EDF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
Zenas BioPharma, Inc. (ZBIO) is a Sell

Is Zenas BioPharma, Inc. a Buy, Sell or Hold?

  • The current Zenas BioPharma, Inc. [ZBIO] share price is $35.81. The Score for ZBIO is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • ZBIO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EDF Stock Price Chart

What is Virtus Stone Harbor Emerging Markets Income Fund's stock price today?

  • The Virtus Stone Harbor Emerging Markets Income Fund share price today is $4.79
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDF is experiencing selling pressure, which indicates risk of future bearish movement.

ZBIO Stock Price Chart

What is Zenas BioPharma, Inc.'s stock price today?

  • The Zenas BioPharma, Inc. share price today is $35.81
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZBIO is experiencing slight selling pressure.

EDF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 39.95 Sell
Chaikin Money Flow: -47409 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.8 - 4.92) Sell
Bollinger Bands (100): (4.9 - 5.12) Sell

ZBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.86 Buy
Relative Strength Index (14 RSI): 49.55 Sell
Chaikin Money Flow: -89322 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.22 - 39.36) Sell
Bollinger Bands (100): (17.16 - 33.88) Buy

EDF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.8 Sell
20-day SMA: 4.85 Sell
50-day SMA: 4.92 Sell
200-day SMA: 4.98 Sell
8-day EMA: 4.81 Sell
20-day EMA: 4.85 Sell
50-day EMA: 4.91 Sell
200-day EMA: 4.98 Sell

ZBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.84 Sell
20-day SMA: 37.69 Sell
50-day SMA: 32.84 Buy
200-day SMA: 17.75 Buy
8-day EMA: 7.96 Buy
20-day EMA: 3.41 Buy
50-day EMA: 1.4 Buy
200-day EMA: 0.36 Buy

Virtus Stone Harbor Emerging Markets Income Fund Earnings Growth & EDF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.

Virtus Stone Harbor Emerging Markets Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Zenas BioPharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):